Back to search
FDAFDA · Food and drugs·Recall number D-0063-2022

MIC/B12A 25/50/50MG/ML 1MG/ML MDV, Red Mountain Compounding Rx

Published November 3, 2021 · Recall initiated: August 13, 2021

Summary

FDA records drug Class II recall D-0063-2022, published November 3, 2021 and initiated August 13, 2021. Recalling firm: First Royal Care Co. LLC, dba Red Mountain Compounding Pharmacy; Status: Terminated; Reported quantity: N/A; Lot: all lots within expiry. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Lack of Assurance of Sterility: FDA inspection raised sterility assurance concerns

What to do

Voluntary: Firm initiated

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
First Royal Care Co. LLC, dba Red Mountain Compounding Pharmacy
Distributor
494 patients/consumers received prescriptions and are located in AZ, CA FL, MN, MT, TX, and UT.
Lot
all lots within expiry
Risk classification
Class II
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was MIC/B12A 25/50/50MG/ML 1MG/ML MDV, Red Mountain Compounding Rx recalled?

Yes. FDA published recall D-0063-2022 on November 3, 2021. Reported hazard: Lack of Assurance of Sterility: FDA inspection raised sterility assurance concerns

What should I do if I have this product?

Voluntary: Firm initiated